This webinar will present and discuss managing COVID in patients with various defects of the Type1 IFN pathway- such as APECED, Type 1 IFN LOF PID and other patients with anti- Type 1 IFN Abs.
• Mikko Seppanen, MD, PhD
Helsinki University Central Hospital, Finland
• Bénédicte Neven, MD
Necker Children Hospital, Paris, France
• Michail Lionakis, M.D., Sc.D.
National Institute of Allergy and Infectious Diseases, United States
• Paul Bastard
Imagine Institute, Paris, France